About Viome Life Sciences
Viome Life Sciences is a private company based in Bellevue, Washington. It has reported $161,510,153 raised in six offerings on Form D since July 2017. Its chief executive is Naveen Jain.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2024 | Aug 28, 2024 | $25,442,535of $30.0M target | 44 | $578K | Equity, OptionsRule 506(b) | Form D ↗ |
| Sep 27, 2022 | Oct 11, 2022 | $67,004,494of $96.8M target | 34 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Jan 28, 2021 | Feb 11, 2021 | $3,000,000of $12.5M target | 2 | $1.5M | Debt, Convertible Promissory Note & WarrantRule 506(b) | Form D ↗ |
| Nov 12, 2019 | Nov 27, 2019 | $36,463,122of $105.9M target | 18 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jun 21, 2018 | Jul 3, 2018amended Aug 2, 2018 | $14,600,000of $21.0M target | 6 | $2.4M | Debt, CONVERTIBLE PROMISSORY NOTESRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 13, 2017 | Jul 28, 2017 | $15,000,002fully sold | 2 | $7.5M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $161,510,153 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Viome Life Sciences's Form D filed Aug 28, 2024.
NJ
Naveen Jain
CEO and director
CK
Christopher Kitze
Director
WO
William Owens
Director
EA
Erik Anderson
Director
AM
Alex Morgan
Director
TG
Teymour Boutros-Ghali
Director
Earlier filings also listed Steven Sansom (director, last listed Oct 2022), Gregory Moore (director, last listed Oct 2022), Eiichiro Kimura (director, last listed Oct 2022), George Montgomery (director, last listed Feb 2021) and Deepak Savadatti (executive officer, last listed Nov 2019).